![Andrew May](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Andrew May is a Director at Intellia Therapeutics, Inc. and Chief Scientific Officer at Caribou Biosciences, Inc. He is on the Board of Directors at Intellia Therapeutics, Inc.
He received his undergraduate degree from the University of Oxford and a doctorate degree from the University of Oxford.
| Unternehmen | Position | Ende |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| INTELLIA THERAPEUTICS, INC. | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
